# OnCo record nct06938867 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06938867/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06938867", "NCT06938867" ;
  schema:name "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant"@en ;
  schema:description "A phase 1/2 trial of SNIPR001 consists of genetically modified bacteriophages specifically targeting Escherichia coli in advanced solid tumours, run by SNIPR Biome Aps., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06938867/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06938867> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2025-02-25" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> .